Reaction Details Report a problem with these data
Target
Interleukin-2
Ligand
BDBM412404
Substrate
n/a
Meas. Tech.
Human ELISA assay
IC50
26.0±n/a nM
Citation
Chen, S; Bohnert, G; Jiang, J; Xia, Z Compounds for inflammation and immune-related uses US Patent US10399967 Publication Date 9/3/2019
More Info.:
Target
Name:
Interleukin-2
Synonyms:
IL-2 | IL2 | IL2_HUMAN | INN=Aldesleukin | Interleukin-2 | Interleukin-2 (IL-2) | T-cell growth factor | TCGF
Type:
Enzyme
Mol. Mass.:
17630.05
Organism:
Homo sapiens (Human)
Description:
P60568
Residue:
153
Sequence:
MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT
Inhibitor
Name:
BDBM412404
Synonyms:
N-(5-(2-chloro-5-((6- (trifluoromethyl)pyridin-2- yl)oxy)phenyl)pyrazin-2-yl)-4- methylnicotinamide | US10399967, Compound 34
Type:
Small organic molecule
Emp. Form.:
C23H15ClF3N5O2
Mol. Mass.:
485.846
SMILES:
Cc1ccncc1C(=O)Nc1cnc(cn1)-c1cc(Oc2cccc(n2)C(F)(F)F)ccc1Cl